Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 released, replacing the previous v3.2.0. The update does not modify the study details or page content.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding notice that warned about potential data delays and provided NIH Clinical Center operating status; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo additions or deletions were detected. The page content and layout appear unchanged between the old and new versions.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference3%

- Check78 days agoChange DetectedUpdated core term from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and bumped revision from v3.0.2 to v3.1.0, indicating terminology refinement and a new version.SummaryDifference0.2%

- Check93 days agoChange DetectedRevision updated to v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.